Guardant Health
GH
#1154
Rank
C$28.13 B
Marketcap
C$207.98
Share price
1.30%
Change (1 day)
55.61%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

EPS for Guardant Health (GH)

EPS in 2026 (TTM): C-$4.86

According to Guardant Health 's latest financial reports the company's current EPS (TTM) is C-$5.00. In 2025 the company made an earnings per share (EPS) of C-$4.74 an increase over its 2024 EPS that were of C-$5.10.

EPS history for Guardant Health from 2018 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C-$4.862.47%
2025C-$4.74-7.02%
2024C-$5.10-16.82%
2023C-$6.13-33.13%
2022C-$9.1760%
2021C-$5.7355.04%
2020C-$3.70207.14%
2019C-$1.20-19.81%
2018C-$1.50

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Neogen
NEOG
C-$0.36-92.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Natera
NTRA
C-$3.51-29.80%๐Ÿ‡บ๐Ÿ‡ธ USA